| Dec'09 | Dec'08 | Dec'07 | ||||
|---|---|---|---|---|---|---|
Changes in assets and liabilities | ||||||
Net income for the year | ||||||
1,281 | 2,654 | 1,703 | ||||
Depreciation and amortization | ||||||
-343 | -341 | -397 | ||||
Foreign exchange and monetary loss (gain), net | ||||||
422 | -1,265 | 438 | ||||
Federal tax repayment program (Refis) gain | ||||||
-255 | 0 | 0 | ||||
Interest accrued | ||||||
415 | 345 | 246 | ||||
Accrual for contingencies and disputed taxes payable, operating activities | ||||||
46 | 48 | 47 | ||||
Accrual for derivatives | ||||||
-45 | 294 | -415 | ||||
Gain on sale of short-term investments | ||||||
0 | 0 | -65 | ||||
Gain on dilution of interest in Namisa | ||||||
0 | -1,667 | 0 | ||||
Deferred income tax expense (benefit) | ||||||
52 | -201 | -85 | ||||
Equity in results of affiliated companies, operating activities | ||||||
-809 | -127 | -76 | ||||
Allowance for doubtful accounts | ||||||
74 | 51 | 3 | ||||
Other, operating activities | ||||||
145 | -166 | -24 | ||||
Trade accounts receivable, operating assets | ||||||
99 | -137 | 152 | ||||
Inventories, operating assets | ||||||
267 | -408 | 97 | ||||
Recoverable taxes, operating assets | ||||||
-139 | -134 | 49 | ||||
Other, operating assets | ||||||
363 | 71 | -137 | ||||
Trade accounts payable, operating liabilities | ||||||
-728 | 336 | -54 | ||||
Payroll and related charges, operating liabilities | ||||||
15 | 6 | 11 | ||||
Taxes payable, operating liabilities | ||||||
101 | -229 | 64 | ||||
Interest paid | ||||||
-809 | -393 | -381 | ||||
Other, operating liabilities | ||||||
46 | 118 | 170 | ||||
Net cash provided by operating activities | ||||||
40 | 2,067 | 1,264 | ||||
Additions to property, plant and equipment | ||||||
930 | 886 | 632 | ||||
Additions to investments | ||||||
-143 | 0 | 0 | ||||
Purchase of short-term investments and debt securities | ||||||
0 | 0 | -437 | ||||
Restricted deposits from legal proceedings | ||||||
-367 | -176 | -561 | ||||
Business acquisitions, net of cash acquired | ||||||
0 | 0 | 348 | ||||
Proceeds received from insurance claims | ||||||
0 | 160 | 134 | ||||
Proceeds (payments) from settlement of derivative instruments | ||||||
161 | -1,006 | 0 | ||||
Financial instruments guarantee margin, investing activities | ||||||
565 | -1,347 | 0 | ||||
Loans to related parties | ||||||
-207 | 49 | 121 | ||||
Net cash used in investing activities | ||||||
-829 | -1,292 | -1,091 | ||||
Proceeds from prepayment agreements | ||||||
0 | 3,041 | 0 | ||||
Intercompany loan | ||||||
0 | -500 | 0 | ||||
Proceeds | ||||||
4,053 | 1,630 | 1,659 | ||||
Repayments | ||||||
1,428 | 919 | 1,397 | ||||
Purchase of Treasury stock | ||||||
-736 | -147 | -32 | ||||
Dividends and interest on stockholders equity, financing activities | ||||||
-1,017 | -1,238 | -352 | ||||
Net cash provided by (used in) financing activities | ||||||
872 | 1,867 | -122 | ||||
Effects of changes in exchange rates on cash and cash equivalents | ||||||
356 | -313 | 203 | ||||
Increase in cash and cash equivalents | ||||||
439 | 2,329 | 254 | ||||
Interest | ||||||
809 | 393 | 381 | ||||
Income taxes | ||||||
375 | 446 | 821 | ||||
Fair value of assets acquired | ||||||
0 | 0 | 475 | ||||
Fair value of liabilities assumed | ||||||
0 | 0 | -35 | ||||
Total purchase price | ||||||
0 | 0 | 440 | ||||
Amount payable | ||||||
0 | 0 | -90 | ||||
Cash acquired | ||||||
0 | 0 | -2 | ||||
Purchase price, net of cash acquired | ||||||
0 | 0 | 348 | ||||
Interest on stockholders equity and dividends unpaid in the year | ||||||
220 | 432 | 298 | ||||
Stock cancellation | ||||||
413 | 109 | 0 | ||||
Effects of FASB Statement No. 158, net of taxes, recognized as accumulated other comprehensive income | ||||||
204 | -239 | 234 | ||||
Changes in fair value of available-for-sale securities, net of taxes, recognized as accumulated other comprehensive income | ||||||
23 | 4 | -30 | ||||